z-logo
open-access-imgOpen Access
Long non‐coding RNA TUG 1 promotes migration and invasion by acting as a ce RNA of miR‐335‐5p in osteosarcoma cells
Author(s) -
Wang Yong,
Yang Tao,
Zhang Zhen,
Lu Ming,
Zhao Wei,
Zeng Xiandong,
Zhang Weiguo
Publication year - 2017
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.13201
Subject(s) - osteosarcoma , rna , oncogene , cancer research , competing endogenous rna , messenger rna , chemistry , biology , long non coding rna , cell , gene , biochemistry , cell cycle
Long non‐coding RNA (lnc RNA ) have been the focus of increasing attention due to the role they play in many diseases, including osteosarcoma. The function of taurine upregulated gene 1 ( TUG 1) and its mechanism in osteosarcoma remain unclear. In our research, we found that TUG 1 was elevated and correlated with a poor prognosis in osteosarcoma patients. In addition, the following functional experiment showed that decreased TUG 1 could remarkably inhibit osteosarcoma cell migration and invasion, indicating that TUG 1 functioned as an oncogene in osteosarcoma. Moreover, we revealed that TUG 1 and Rho‐associated coiled‐coil‐containing protein kinase 1 ( ROCK 1), a metastasis‐related gene targeted by micro RNA ‐335‐5p (miR‐335‐5p), had the same miR‐335‐5p combining site. The subsequent luciferase assay verified TUG 1 was a target of miR‐335‐5p. Furthermore, the results of a real‐time quantitative PCR showed that TUG 1 and miR‐335‐5p could affect each other's expression. respectively. Finally, we affirmed that TUG 1 affected ROCK 1 expression and ROCK 1‐mediated migration/invasion by working as a competitive endogenous RNA (ce RNA ) via miR‐335‐5p. In summary, the findings of this study, based on ce RNA theory, combining the research foundation of miR‐335‐5p and ROCK 1, and taking TUG 1 as a new study point, provide new insight into molecular‐level reversing migration and invasion of osteosarcoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here